Evidence map›Paper›PMID 32093083›Full record

ArticleMicroorganisms2020

Development of a Lyophilization Process for

Lu Liang, Nicholas B Carrigy, Samuel Kariuki, Peter Muturi, Robert Onsare, Tobi Nagel, Reinhard Vehring, Phillippa L Connerton, Ian F Connerton

Abstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Bacteriophage Production in Compliance with Regulatory Requirements.Methods in molecular biology (Clifton, N.J.) · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Foodborne Pathogen Campylobacter.Microorganisms · 2021
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lu LiangDivision of Microbiology, Brewing and Biotechnology, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UK.
Nicholas B CarrigyDepartment of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.
Samuel KariukiCenter for Microbiology Research, Kenyan Medical Research Institute, 54840 Nairobi, Kenya.
Peter MuturiCenter for Microbiology Research, Kenyan Medical Research Institute, 54840 Nairobi, Kenya.
Robert OnsareCenter for Microbiology Research, Kenyan Medical Research Institute, 54840 Nairobi, Kenya.
Tobi NagelPhages for Global Health, Oakland, CA 94618, USA.
Reinhard VehringDepartment of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.
Phillippa L ConnertonDivision of Microbiology, Brewing and Biotechnology, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UK.
Ian F ConnertonDivision of Microbiology, Brewing and Biotechnology, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UK.

Funding

Biotechnology and Biological Sciences Research Council BB/P02355X/1
6 · The paper itself

Abstract

Bacteriophages are a sustainable alternative to control pathogenic bacteria in the post-antibiotic era. Despite promising reports, there are still obstacles to phage use, notably titer stability and transport-associated expenses for applications in food and agriculture. In this study, we have developed a lyophilization approach to maintain phage titers, ensure efficacy and reduce transport costs of

Indexed as

bacteriophageCampylobacterlyophilizationphage stabilityphage transportation

Identifiers

PMID32093083
PMCPMC7074765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.